TipRanks
Endonovo Therapeutics (ENDV)
OTHER OTC:ENDV
US Market
ENDV
Endonovo Therapeutics
RESEARCH TOOLSreports
Want to see ENDV full AI Analyst Report?

Endonovo Therapeutics (ENDV) Balance Sheet

24 Followers

Endonovo Therapeutics Balance Sheet

Endonovo Therapeutics's total assets for Q2 2026 were $44.84K, an increase of 128.02% from the previous quarter. ENDV total liabilities were $30.09M for the fiscal quarter, a 2.08% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Assets
$ 19.30K$ 19.29K$ 639.66K$ 1.28M$ 2.01M
Total Liabilities
$ 28.89M$ 26.82M$ 24.75M$ 33.46M$ 17.78M
Total Equity Gross Minority
$ -28.87M$ -26.80M$ -24.11M$ -32.18M$ -15.77M
Other Metrics
Currency in USD

Endonovo Therapeutics Debt to Assets